What’s the Newest in Fertility and Pregnancy Issues in IBD
This presentation will be a discussion of recent data regarding safety of IBD medications during pregnancy and outcomes in children that were exposed to mediation in utero.
This presentation was originally recorded at the Best of the Annual Conferences in Digestive Diseases on June 13, 2015 in Rosemont, IL.
Medium: Video with PPT, eLearning
Target Audience
This activity has been designed for Gastroenterologist, Surgeons, Nurses, Nurse Practitioners, Physician Assistants, and Residents/Fellows.
Learning Objectives
After completing this activity, the participant will demonstrate the ability to:
- Appraise the safety of IBD medication during pregnancy;
- Cite predictors for a healthy and safe pregnancy in IBD;
- List the latest data regarding fertility and fertility treatment in IBD.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
The University of Chicago Pritzker School of Medicine designates this enduring material for a maximum .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
To view this activity, you will need to visit the Learning @ the Forefront website at: